Correction: The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancerC. Hage, V. Rausch,N. Giese, T. Giese, F. Schönsiegel, S. Labsch, C. Nwaeburu,J. Mattern, J. Gladkich,I. HerrCell Death & Disease(2024)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要